Glucagon-like peptide-1 (GLP-1) is an incretin hormone, one of several gut-derived peptides secreted in response to nutrient intake that promote insulin release
This cell line has also been validated in a dose-response assay using a small molecule agonist, Danuglipron
This article examines the relationship between GLP-1 agonists and joint pain, explores potential contributing factors such as rapid weight loss and increased activity, and provides guidance on managing symptoms and recognising when medical review is needed
Despite their effectiveness, they come with a range of potential side effects that can impact patient comfort and adherence to treatment
Prior authorization: Even when coverage exists, insurance plans usually ask your doctor to fill out extra paperwork before theyll approve a medication, which can delay access to treatment
Around six months after giving birth to her second daughter, Adira, and after she stopped breastfeeding, she began weekly injections